Page last updated: 2024-09-02
fingolimod hydrochloride and Epithelial Neoplasms
fingolimod hydrochloride has been researched along with Epithelial Neoplasms in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bae, DS; Cho, YJ; Choi, CH; Choi, JJ; Do, IG; Jeon, HK; Kim, BG; Kim, TJ; Lee, JW; Lee, YY; Ryu, JY; Song, SY; Yoon, G | 1 |
Other Studies
1 other study(ies) available for fingolimod hydrochloride and Epithelial Neoplasms
Article | Year |
---|---|
Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer.
Topics: Adenocarcinoma, Clear Cell; Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Protein Kinase Inhibitors; RNA, Small Interfering; Sphingosine; Xenograft Model Antitumor Assays | 2015 |